Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology Officer (CTO), effective ...

Ryan Amberger is headed to Los Alamos National Laboratory, where he will spend the next year studying nuclear astrophysics — specifically, the process behind the creation of half of the elements ...

Dr. Schaffer has been CTO at ARTMS Inc. (ARTMS) (acquired by Telix in 2024) for the past seven years, as well as Director, Life Science at TRIUMF, Canada's particle accelerator research ...

DESY scientists have taken a major step in refining laser plasma acceleration, a technology that could revolutionize particle ...

Laser-plasma accelerators can accelerate particles over distances that are up to 1,000 times shorter than those required by ...

Physicists are sketching the designs of a particle accelerator that would be radically smaller and cheaper than existing ...

Scientists from Germany's DESY have come up with a two-stage correction approach to speed up electrons just like they do with ...